rhs_col

Talks

  • Functional characterization of reconstructed skin containing in vitro generated Langerhans cells. EUSAAT 2015 - 16th Annual Congress of EUSAAT / Linz 2015 - 19th European Congress on Alternatives to Animal Testing, Linz / Austria, 22 September 2015
  • Skin models in pharmacology and toxicology - opportunities and potential limitations of alternative methods (in German). Goethe University Frankfurt, Campus Riedberg, Frankfurt am Main, 24 June 2015
  • Evaluation of synthetic antimicrobial peptides for topical skin therapy. 2015 Glycolipid Meeting - Structures, functions, and interactions of Membrane Compounds, Hamburg / Germany, 5 June 2015
  • Human skin models for the characterisation of immunological processes - opportunities and limitations of alternative methods (in German). 19th Annual Meeting of the Society for Dermopharmacy, Berlin / Germany, 17 March 2015
  • Dendritic cells as regulators of skin inflammation (in German). Fortbildungskolloquium der Klinik und Poliklinik für Dermatologie und Allergologie der LMU München, Munich / Germany, 21 January 2015
  • Human skin models for the characterisation of xenobiotic biotransformation and immunological processes (in German). Life Science Seminar Beiersdorf AG, Hamburg / Germany, 21 August 2014
  • Taking care of your skin (in German). Summer University of the Freie Universität Berlin, Berlin / Germany, 19 August 2014
  • Langerhans cells as skin immune sentinels – shaping immune responses during inflammation. Heinz Maurer Symposium "Review and Preview in Science for Healthy Skin", Boppard / Germany, 28 June 2014
  • Infection models for localised candidosis - From molecular pathogenesis to testing of antifungal agents (in German). DPhG Vortragsprogramm Landesgruppe Niedersachsen / Untergruppe Braunschweig, Braunschweig / Germany, 22 May 2014
  • Antifungal agents - fundamentals and pharmaceutical aspects (in German). Fortbildungsveranstaltung der Apothekerkammer Berlin, Berlin / Germany, 22 January 2014
  • Reconstructed human skin as disease models. Symposium of GD Society for Dermopharmacy on "Dermatotoxicological and other Safety Testing Methods without Animlals - Status November 2013", Berlin / Germany, 28 November 2013
  • Reconstructed human skin as alternative test system in pharmacology. Universidade de São Paulo (USP), Faculdade de Ciências Farmacêuticas, São Paulo / Brazil, 22 November 2013
  • Reconstructed human skin as alternative test system in pharmacology. Universidade Estadual de Campinas (UNICAMP), Faculdade de Ciências Médicas, Campinas / Brazil, 21 November 2013
  • Phase I biotransformation of testosterone by human skin and reconstructed skin tissues.  EUSAAT 2013 - 15th Annual Congress of EUSAAT / Linz 2013 - 18th European Congress on Alternatives to Animal Testing / ESNATS Conference, Linz / Austria, 18 September 2013
  • Increased cutaneous absorption reflects impaired barrier function of reconstructed skin models mimicking keratinisation disorders.  EUSAAT 2013 - 15th Annual Congress of EUSAAT / Linz 2013 - 18th European Congress on Alternatives to Animal Testing / ESNATS Conference, Linz / Austria, 15 September 2013
  • Human skin models for skin infections and inflamed skin (in German). 17th Annual Meeting of the Society for Dermopharmacy, Mainz / Germany, 22 March 2013
  • In vitro human tissue models for infectious and inflammatory skin diseases. European Society of Toxicology in Vitro 2012 International Conference (ESTIV2012), Lisbon / Portugal, 17 October 2012
  • Characterization of reconstructed human skin following topical treatment with glucocorticoid creams. EUSAAT 2012 - 14th Annual Congress of EUSAAT / Linz 2012 - 17th European Congress on Alternatives to Animal Testing, Linz / Austria, 07 September 2012
  • Esterase Activity in Excised and Reconstructed Human Skin - Biotransformation of Prednicarbate and the Model Dye Fluorescein Diacetate. EUSAAT 2012 - 14th Annual Congress of EUSAAT / Linz 2012 - 17th European Congress on Alternatives to Animal Testing, Linz / Austria, 06 September 2012
  • Glucocorticoids for the skin (in German). DPhG Vortragsprogramm Landesgruppe Berlin-Brandenburg, Berlin / Germany, 26 April 2012
  • Glucocorticoids on the skin (in German). 86. Zentrale Fortbildungsveranstaltung der Landesapothekerkammer Hessen, Gießen / Germany, 17 March 2012
  • Modulation of Proinflammatory Responses in Human Skin Cells by Cross-Talk between TLR and S1P Signalling. 2011 ESDR Academy for Future Leaders in Dermatology, Cascais / Portugal, 11 November 2011
  • Organisation of the symposium of the section "Pharmacology and Toxicology" of the German Pharmaceutical Society „In vitro skin models as alternative pharmacological test systems“ and talk "In vitro infection models for localised candidosis" (in German). Annual Meeting of the German Pharmaceutical Society, Braunschweig / Germany, 06 October 2010
  • Comparative analysis of esterase activity in reconstructed human skin models and excised human skin. Jahrestagung der Deutschen Pharmazeutischen Gesellschaft, Braunschweig / Germany, 05 October 2010
  • Models of localized Candida infections based on in vitro reconstituted human epithelia. ESTIV 2010 - the 16th International Congress on In Vitro Toxicology / EUSAAT 2010 - 13th Annual Congress of EUSAAT / Linz 2010 - 16th Congress on Alternatives to Animal Testing, Linz / Austria, 02 September 2010
  • In vitro infection models of localized Candida infections. Skin in Vitro 2010 Symposium, Frankfurt a. Main / Germany, 08 June 2010
  • In vitro infection models for localised candidosis (in German). 14th Annual Meeting of the Society for Dermopharmacy, Berlin / Germany, 24 March 2010
  • Toll-like receptors - new targets for dermatotherapy (in German). 14th Annual Meeting of the Society for Dermopharmacy, Berlin / Germany, 23 March 2010
  • Polymerase alpha Inhibition – from Molecular Modelling to Nanotechnology in Human Skin Cancer Therapy. Makassar International Symposium on Pharmaceutical Science 2009 - Recent Progress in Drug Discovery, Makassar / Indonesia, 19-20 March 2009
  • Humane Epithelzellen ermöglichen direkte antifungale Abwehr durch Toll-like Rezeptor 4-vermittelten Signalweg. 6. Veranstaltung der Deutschen Pharmazeutischen Gesellschaft (DPhG), Landesgruppe Berlin-Brandenburg "Der wissenschaftliche Nachwuchs stellt sich vor", Berlin / Germany, 04 July 2008
  • Cytokines are critically involved in PMN-dependent and TLR4-mediated protective mechanisms against oral C. albicans infections. 41. Wissenschaftliche Tagung der Deutschsprachigen Mykologischen Gesellschaft e. V., Berlin / Germany, 08 September 2007
  • Studying innate immune responses during Candida infections using in vitro human tissue models. 4th SkinEthic Workshop, Nizza / France, 06 September 2007
  • Role of Toll-like Receptor 4 in the protection of mucosal surfaces against Candida albicans infections. Statusworkshop der DGHM-Fachgruppe "Eukaryotic Pathogens", Stuttgart / Germany, 23 February 2007
  • Orale Epithelzellen ermöglichen direkte antifungale Abwehr durch Toll-like Rezeptor 4-vermittelten Signalweg. 40. Wissenschaftliche Tagung der Deutschsprachige Mykologischen Gesellschaft e. V. gemeinsam mit der Österreichischen Gesellschaft für Medizinische Mykologie, Innsbruck / Austria, 07 September 2006
  • Zentrale Rolle des epithelialen Toll-like Rezeptors 4 in einem Modell der oralen Kandidose. 40. Wissenschaftliche Tagung der Deutschsprachigen Mykologischen Gesellschaft e. V., Leipzig / Germany, 09 September 2005
  • Quantitative expression of Toll-like receptors during infection of human keratinocytes with Candida albicans. Graduiertenkolleg „Infektion und Immunität” Statusseminar, Hirschegg (Kleinwalsertal) / Austria, 03 July 2004
  • Quantitative expression of Toll-like receptors during infection of human keratinocytes with Candida albicans. Graduiertenkolleg „Infektion und Immunität” Statusseminar, Munich / Germany, 05 December 2003
  • Quantitative Real-time PCR. Graduiertenkolleg „Infektion und Immunität“ Methodenseminar, Munich / Germany, 08 September 2003